Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment
Launched by HJN SVERIGE AB/NEKO HEALTH · May 19, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new, non-invasive technology that uses sound waves to measure how stiff your arteries are. Arterial stiffness is an important factor in understanding heart health and can help assess the risk for conditions like hypertension, heart disease, and diabetes. The researchers aim to see how well this new method works in a real-world healthcare setting and whether combining different types of health data can improve the accuracy of assessing cardiovascular risk.
To participate in the trial, you should be an adult patient who is already receiving care at one of the study sites and able to give your consent. You won't be eligible if you have significant cognitive issues, cannot understand the study information in English or Swedish, or have other serious health conditions. If you choose to participate, you will help researchers learn more about heart health, and you may contribute to the development of better tools for assessing cardiovascular disease risk.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation.
- • Patients with signed informed consent
- Exclusion criteria:
- • Cognitive impairment
- • Patients unable to understand the oral and written study information in Swedish or English
- • Other severe disorder or terminal disease, e.g. infection/sepsis, severe COPD or metastatic cancers.
- • Patients unable to provide an informed consent
About Hjn Sverige Ab/Neko Health
HJN Sverige AB, operating under the brand Neko Health, is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative technology and comprehensive health monitoring solutions. With a focus on harnessing cutting-edge artificial intelligence and data analytics, Neko Health aims to enhance patient outcomes and streamline clinical research processes. The organization is committed to fostering collaboration with medical professionals and research institutions to facilitate the development of groundbreaking therapies and improve overall health management. Through its rigorous approach to clinical trials, HJN Sverige AB seeks to contribute significantly to the future of personalized medicine and healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Stockholm, , Sweden
Stockholm, , Sweden
Patients applied
Trial Officials
Henrik Hellqvist, MD
Principal Investigator
Neko Health AB
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported